InsidersTradesSigma
Total declarations
Companies
▲ Purchases (15 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Muralidhar Bali, Director. Officer active across 2 companies, notably Reneo Pharmaceuticals, Inc.. In total, 15 filings have been logged. Total volume traded: €3.2m. The latest transaction was filed on 19 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations15 total
€269,5451,472,126 shares@ €0.18310.78% mcap100.0% of flow
Common Stock
SEC:0001209191-22-030549:0·
Ideal exit: 13 Feb 2023 (T+270)
€802,610111,736 shares@ €7.183154.3% of flow
Common Stock
SEC:0001209191-21-046803·
Ideal exit: 10 Apr 2022 (T+270)
€802,610111,736 shares@ €7.183127.1% of flow
Common Stock
SEC:0001209191-21-046803:0·
Ideal exit: 10 Apr 2022 (T+270)
€161,10120,710 shares@ €7.778910.9% of flow
Common Stock
SEC:0000905718-21-000834·
Ideal exit: 20 Mar 2022 (T+270)
€161,10120,710 shares@ €7.77895.4% of flow
Common Stock
SEC:0000905718-21-000834:0·
Ideal exit: 20 Mar 2022 (T+270)
€247,57732,659 shares@ €7.580716.7% of flow
Common Stock
SEC:0000905718-21-000816·
Ideal exit: 18 Mar 2022 (T+270)
€247,57732,659 shares@ €7.58078.4% of flow
Common Stock
SEC:0000905718-21-000816:0·
Ideal exit: 18 Mar 2022 (T+270)
€129,55816,605 shares@ €7.80244.4% of flow
Common Stock
SEC:0000905718-21-000770:0·
Ideal exit: 5 Mar 2022 (T+270)
€129,55816,605 shares@ €7.80248.8% of flow
Common Stock
SEC:0000905718-21-000770·
Ideal exit: 5 Mar 2022 (T+270)
€92,26312,100 shares@ €7.62516.2% of flow
Common Stock
SEC:0000905718-21-000760·
Ideal exit: 28 Feb 2022 (T+270)
€92,26312,100 shares@ €7.62513.1% of flow
Common Stock
SEC:0000905718-21-000760:0·
Ideal exit: 28 Feb 2022 (T+270)
€10914 shares@ €7.79120.0% of flow
Common Stock
SEC:0000905718-21-000744·
Ideal exit: 22 Feb 2022 (T+270)
€10914 shares@ €7.79120.0% of flow
Common Stock
SEC:0000905718-21-000744:0·
Ideal exit: 22 Feb 2022 (T+270)
€45,5155,915 shares@ €7.69493.1% of flow
Common Stock
SEC:0000905718-21-000738·
Ideal exit: 20 Feb 2022 (T+270)
€45,5155,915 shares@ €7.69491.5% of flow
Common Stock
SEC:0000905718-21-000738:0·
Ideal exit: 20 Feb 2022 (T+270)
15 of 15 declarations
About Muralidhar Bali
Muralidhar Bali is an executive at Reneo Pharmaceuticals, Inc.
